Company Filing History:
1 out of 1 
1 out of 50 
Years Active: 2023
Title: Remko Albert Griep: Innovator in Antibody Humanization
Introduction
Remko Albert Griep is a notable inventor based in Plzen, Czech Republic. He has made significant contributions to the field of biotechnology, particularly in the area of antibody humanization. His innovative work has implications for therapeutic applications and advancements in medical research.
Latest Patents
Griep holds a patent for a "Method for mass humanization of rabbit antibodies." This invention relates to a method for producing a population of 20 or more nucleic acids, each encoding at least one protein comprising at least one immunoglobulin variable domain. The method features a rabbit-derived CDR3 amino acid sequence embedded in essentially human framework sequences. This patent also includes a population of nucleic acids and a population of proteins related to the method and its uses.
Career Highlights
Throughout his career, Remko Albert Griep has worked with several prominent companies in the biotechnology sector. He has been associated with Abcheck s.r.o. and Charles River Laboratories, Inc. His experience in these organizations has allowed him to develop and refine his expertise in antibody engineering and related technologies.
Collaborations
Griep has collaborated with notable professionals in his field, including Jacob E. Gunn Glanville and Vera Molkenthin. These collaborations have contributed to the advancement of research and development in antibody humanization.
Conclusion
Remko Albert Griep's innovative work in the field of antibody humanization showcases his dedication to advancing biotechnology. His contributions through patents and collaborations highlight the importance of innovation in medical research and therapeutic development.